A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

Gut

Volumn 47, Issue 3, 2000, Pages 404-409

  Geboes, K ^a   Riddell, R ^b   Ost A ^c   Jensfelt, B ^d   Persson, T ^d   Lofberg R ^e  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MCMASTER UNIVERSITY   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Astra Zeneca AB ^*  (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biopsy; Inflammation; Scoring system; Ulcerative colitis

Indexed keywords

ARTICLE; CHRONICITY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE CRYPT; INTESTINE ENDOSCOPY; INTESTINE INJURY; NEUTROPHIL; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; ULCERATIVE COLITIS;

BIOPSY; COLITIS, ULCERATIVE; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0033849872     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.3.404     Document Type: Article

References (30)

1. 1 Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997;50:93-105.
2. 2 Riddell RH. Histopathology of ulcerative colitis. In: Allan RW, Rhodes JM, Hanauer SB, et al, eds. Inflammatory bowel disease, 3rd ed. New York: Churchill Livingstone, 1997: 291-309.
3. 3 Goldman H. Colonic mucosal biopsy in inflammatory bowel disease. Surg Pathol 1991;4:3-23.
4. 4 Theodossi A, Spiegelhalter DJ, Jass J, et al. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 1994;35:961-8.
5. 5 Rubio CA, Johansson C, Uribe A, et al. A quantitative method of estimating inflammation in the rectal mucosa: IV. Ulcerative colitis in remission. Scand J Gastroenterol 1984;19:525-30.
6. 6 Seldenrijk CA, Morson BC, Meuwissen SGM, et al. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 1991;32:1514-20.
7. 7 Rubio CA, Johansson C, Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients. Scand J Gastroenterol 1982; 17:1077-81.
8. 8 Tanaka M, Riddell RH, Saito H, et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999;34:55-67.
9. 9 Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology 1987;92:318-28.
10. 10 Schumacher G, Kollberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Scand J Gastroenterol 1994;29:318-32.
11. 11 Janssens J, Geboes K, Delanote C, et al. 5-amino-salicylic acid (5-ASA) enemas are effective in patients with resistent ulcerative colitis. Gastroenterology 1983;84:1198.
12. 12 Bernstein CN, Shanahan F, Anton PA, et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995;42:232-7.
13. 13 Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998;22:983-9.
14. 14 Odze R, Antonioli D, Peppercorn M, et al. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 1993;17:869-75.
15. 15 Wright R, Truelove SC. Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets. Am J Dig Dis 1964;11:847-57.
16. 16 Riley SA, Mani V, Goodman MJ, et al. Microscopic acitivity in ulcerative colitis: what does it mean? Gut 1991;32:174-8.
17. 17 Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988;29:669-74.
18. 18 Gomes P, Claire du Boulay, Smith CL, et al. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27:92-5.
19. 19 Florén CH, Benoni C, Willén R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 1987;22:459-62.
20. 20 Danielsson A, Hellers G, Lyrenas E, et al. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol 1987;22:987-92.
21. 21 Goldman H. Interpretation of large intestinal mucosal biopsy specimens. Hum Pathol 1994;25:1150-9.
22. 22 Stahlberg D, Veress B, Mare K, et al. Leucocyte migration in acute chronic inflammatory bowel disease: comparison of histological assessment and TC-99m-HMPAO labeled leucocyte scan. Am J Gastroenterol 1997;92:283-8.
23. 23 Weldon MJ, Masoomi AM, Britten AJ, et al. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labeled leucocyte single photon emission computerized tomography (SPECT). Gut 1995;36:243-50.
24. 24 Keren DF, Appelman HD, Dobbins III WO, et al. Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease. Hum Pathol 1984;15:757-63.
25. 25 Powell-Tuck J, Day DW, Buckell NA, et al. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982;27:533-7.
26. 26 Tsang P, Rotterdam H. Biopsy diagnosis of colitis: possibilities and pitfalls. Am J Surg Pathol 1999;23:423-30.
27. 27 Jenkins D, Goodall A, Drew K, et al. What is colitis? Statistical approach to distinguish clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol 1988; 41:72-9.
28. 28 Dubucquoi S, Janin A, Klein O, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995;37:242-6.
29. 29 Wright R, Truelove SC. Circulating and tissue eosinophils. Am J Dig Dis 1966;11:831-46.
30. 30 Oshitani N, Campbell A, Kitano A, et al. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol 1996;178:95-9.